en · de · es · pt
peptide-index.peptides5388.com › Faq › Background And Mechanism Of Sr9009 — 2026 Update

Background And Mechanism Of Sr9009 — 2026 Update

By Editorial Desk · published 2025-10-13 · last reviewed 2025-11-04 · Faq

This is a working overview of research chemical, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2025-11-04. Anything still debated is marked as such rather than presented as settled.

Background and Mechanism of SR9009

SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.

SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.

Mechanism and Preclinical Findings

Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.

The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic REV-ERB agonistSmall-molecule ligand; not a hormone or peptide
Molecular formulaC20H24ClN3O4SReported for the free base
CAS Registry Number1379686-30-2Unique chemical identifier
Common synonymsSR9009; stenabolicStenabolic is informal and not an official name
Reported targetsREV-ERBα and REV-ERBβNuclear receptors linked to circadian and metabolic regulation

SR9009 Handling and Quality Control

SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.

Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.

Related pages on this site

Analytical Detection and Stability

Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.

Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.

Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.

Regulation, Testing, and Storage

SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.

Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.

Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.

Analytical Detection and Laboratory Handling

Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.

Further detail

The potato is a starchy tuber that has been grown and eaten for more than 8,000 years. In the 16th century, Spanish explorers in the Americas found Peruvians cultivating potatoes and introduced them to Europe. The potato, an easily grown source of carbohydrates, proteins and vitamin C, spread to many other areas and became a staple food of many cultures. In the 20th century potatoes are eaten on all continents; the method of preparation, however, can modify its nutritional value. Prepared in its skin or peeled and cooked by methods including boiling, grilling, sautéing, and frying, the potato is used as a main dish or as a side dish, or as an ingredient. It is also used as a thickener, or for its by-products (starch or modified starches).

Non-spherical nanoparticles (e.g., prisms, cubes, rods etc.) exhibit shape-dependent and size-dependent (both chemical and physical) properties (anisotropy). Non-spherical nanoparticles of gold (Au), silver (Ag), and platinum (Pt) due to their fascinating optical properties are finding diverse applications. Non-spherical geometries of nanoprisms give rise to high effective cross-sections and deeper colors of the colloidal solutions. The possibility of shifting the resonance wavelengths by tuning the particle geometry allows using them in the fields of molecular labeling, biomolecular assays, trace metal detection, or nanotechnical applications. Anisotropic nanoparticles display a specific absorption behavior and stochastic particle orientation under unpolarized light, showing a distinct resonance mode for each excitable axis.

The plasmon resonance displayed by nanoparticles, gold particles are most often used as an example, can be altered using the interfacial layer. When either anionic or cationic ligands bound to a nanoparticle made of gold for example are increased in length, the wavelength of the plasmon resonance will shift to red. An example of another effect, that has recently been observed by Amendola et al. on small gold nanoparticles, of 10 nm or less, is that dense monolayers that consist of certain specific short chain ligands tend to dampen the surface plasmon resonance effects. Plasmon resonance can be used to analyze the surfactants of the nanoparticle. This principle is based on the so-called Fröhlich condition which states that the refractive index of the surrounding medium of a nanoparticle can be used to tune or alter the frequency of the surface plasmon resonance. The equation that relates both properties is as follows:

A 2018 review found e-cigarette vapor containing reactive oxygen radicals seem to be similar to levels in traditional cigarettes. Glyoxal and methylglyoxal found in e-cigarette vapors are not found in cigarette smoke.

Sources: en.wikipedia.org

Background from the literature

=== Centrally-projecting neurons === As well as neuroendocrine neurons, the PVN contains interneurons and populations of neurons that project centrally (i.e., to other brain regions). The centrally-projecting neurons include

A source rock rich in hydrocarbon material buried deeply enough for subterranean heat to cook it into oil, A porous and permeable reservoir rock where it can accumulate, A caprock (seal) or other mechanism to prevent the oil from escaping to the surface. Within these reservoirs, fluids will typically organize themselves like a three-layer cake with a layer of water below the oil layer and a layer of gas above it, although the different layers vary in size between reservoirs. Because most hydrocarbons are less dense than rock or water, they often migrate upward through adjacent rock layers until either reaching the surface or becoming trapped within porous rocks (known as reservoirs) by impermeable rocks above. However, the process is influenced by underground water flows, causing oil to migrate hundreds of kilometres horizontally or even short distances downward before becoming trapped in a reservoir. When hydrocarbons are concentrated in a trap, an oil field forms, from which the liquid can be extracted by drilling and pumping. The reactions that produce oil and natural gas are often modeled as first order breakdown reactions, where hydrocarbons are broken down to oil and natural gas by a set of parallel reactions, and oil eventually breaks down to natural gas by another set of reactions. The latter set is regularly used in petrochemical plants and oil refineries. Petroleum has mostly been recovered by oil drilling (natural petroleum springs are rare).

=== Gut === The gut-associated lymphoid tissue (GALT) is responsible for distinguishing pathogenic organisms from harmless food proteins and commensal bacteria. Antigens sampled across the intestinal epithelium are presented by CD103+ dendritic cells, which migrate to mesenteric lymph nodes and promote differentiation of Foxp3+ regulatory T cells (Tregs). These Tregs subsequently return to the intestinal lamina propria, where cytokines such as interleukin-10 and transforming growth factor-β (TGF-β) contribute to the maintenance of immune tolerance and suppression of allergic T helper 2 (Th2) responses. Disruption of these regulatory pathways may contribute to allergic sensitization and the development of food allergy. Impairment of the intestinal epithelial barrier, altered antigen processing, inflammation, or reduced regulatory T-cell activity may shift immune responses toward IgE-mediated hypersensitivity. Such defects in oral tolerance have been associated with increased Th2 polarization, elevated allergen-specific IgE production, and reduced regulatory immune activity. Environmental and dietary factors, including vitamin D deficiency, infections, antibiotic exposure, and changes in food processing, may also influence allergy development through their effects on gut immunity and epithelial integrity. The intestinal microbiome is increasingly recognized as an important factor in allergy development. Early-life alterations in the composition and diversity of the intestinal microbiota have been associated with an increased risk of food allergy and atopic disease.

Sources: en.wikipedia.org

Reference notes

==== Perissodactyl research ==== Tissier & Smith (2026) reconstruct the early evolutionary history of Perissodactyla on the basis of a new phylogenetic study, recovering purported horse relatives Hyracotherium and Pliolophus as not belonging to Hippomorpha, and reporting evidence of rapid dispersals of Pliolophus and Cardiolophus in the northern continents around the Paleocene–Eocene thermal maximum. New fossil material of Ancylotherium hennigi, providing new information on the anatomy of members of this species, is described from the Plio-Pleistocene strata from Laetoli (Tanzania) by Harrison & Kwekason (2026). Radović et al. (2026) identify dental remains of Tapirus arvernensis from the Pliocene strata from the Ridjake fossil site (Serbia). Sun et al. (2026) describe new fossil material of Tapirus sanyuanensis from the Pleistocene strata from Renzidong Cave (Anhui, China), providing information on changes in anatomy of members of this species during their ontogeny, as well as evidence of morphological differences between populations of this species from Renzidong Cave and from the Wushan Longgupo Site (Chongqing, China). Handa et al. (2026) describe rhinocerotid fossils from the Phra Phut sandpit (Thailand), interpreted as indicative of late Miocene age of the studied assemblage, and report evidence of similarity of composition of the studied assemblage and other late Miocene rhinocerotid assemblages from sandpits in Chaloem Phra Kiat District in Nakhon Ratchasima. Sanisidro & Gutiérrez-Marco (2026) describe fossil material of Brachydiceratherium sp.

Measurement tools, such as goniometers and inclinometers, aid in standardized quantification of joint motion relative to normative values or ranges. Tests that follow functional movements, such as reaching overhead, squatting, or rotating the neck, are used to evaluate whether reduced ROM translates into activity limitation. When hypomobility is regional, clinicians can use condition-specific values to compare the patient's ROM values against. For instance, in the shoulder, adhesive capsulitis (frozen shoulder) is defined by marked loss of both active and passive motion (particularly external rotation and abduction). For the knee, postoperative arthrofibrosis is typically diagnosed when extension loss exceeds 10° or flexion is limited to less than 100°, with more severe forms showing a flexion deficit of 25° or greater. In the spine, decreased ROM is assessed using values developed for ankylosing spondylitis and related disorders. The Modified Schober Test measures lumbar flexion. An increase of less than 5 cm indicates limited motion, chest expansion of 2.5 cm or less suggests thoracic restriction, and an occiput-to-wall distance greater than 2 cm shows thoracic or cervical extension limitation. The Bath Ankylosing Spondylitis Metrology Index (BASMI) provides a composite score summarizing these spinal mobility measures and is widely used to quantify skeletal hypomobility.

If this is the case, such a duplication must have happened early in animal evolution (more than 700 million years ago), as genes that encode for all three subunits of troponin have been found in every invertebrate phyla except the Cnidaria (or equivalently, all Bilaterian phyla). The ancestral gene pair most closely resembled TNNI2-TNNT3.

Aden Colony (Arabic: مُسْتْعَمَرَةْ عَدَنْ, romanised: Musta'marat 'Adan) was a crown colony of the United Kingdom from 1937 to 1963 located in the southern part of modern-day Yemen. It consisted of the port city of Aden and also included the outlying islands of Kamaran, Perim and the Khuria Muria archipelago with a total area of 192 km2 (74 sq mi). Initially a key port for the British East India Company, it was annexed by the British in 1839 to secure maritime routes and prevent piracy in the Arabian Sea. Its strategic position at the entrance to the Red Sea made it a vital stopover for ships traveling between Europe, India, and the Far East, especially after the opening of the Suez Canal in 1869. Aden quickly became a major coaling station and transit hub for British shipping, and its significance to the British Empire grew throughout the 19th and early 20th centuries. Prior to 1937, Aden had been governed as part of British India (originally as the Aden Settlement subordinate to the Bombay Presidency, and then as a Chief Commissioner's province). On 1 April 1937, Aden was separated from British India to become a Crown colony under the Government of India Act 1935, consisting of the city of Aden and its surrounding areas. The colony experienced rapid development due to its thriving port, but it was also marked by growing civil unrest. Economic inequality, labour strikes, and the rise of Arab nationalism contributed to increasing tensions, which were intensified by the anti-colonial sentiment in the Middle East.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.

Is SR9009 approved for human use?

No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.

How does SR9009 differ from natural REV-ERB ligands?

Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.

What is SR9009?

It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.

Network